Status:
COMPLETED
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform
Lead Sponsor:
Pusan National University Hospital
Conditions:
PreDiabetes
Glucose Metabolism Disorders
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to collect a variety of clinical data and blood glucose changes using a continuous glucose monitoring device for high-risk diabetes patients (prediabetes) in order to deve...
Detailed Description
After being informed about the study and potential risks, all patients giving written informed consent wear a continuous glucose monitoring device ("iPro2" professional continuous glucose monitoring, ...
Eligibility Criteria
Inclusion
- Above 18 years old.
- Prediabetes
- Fasting plasma glucose : 100\~125mg/dL, fasting is defined as no caloric intake for at least 8 hours.
- OR
- 2-hour plasma glucose during 75g oral glucose tolerance test : 140 \~ 199mg/dL
- OR
- Glycated hemoglobin(HbA1c) : 5.7\~6.4% (39-47mmol/mol)
Exclusion
- with a history of newly diagnosed and treated cancer within the last 5 years
- with a history of hospitalization for active disease within the last 3 months
- with a history of severe cardiovascular disease within the last 3 months
- with a history of steroid treatment in the last 3 months
- people who have had major surgery planned within the last 3 months or who have had surgery within 3 months
- people who are pregnant or have been in the last 3 months after giving birth
Key Trial Info
Start Date :
May 11 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04369833
Start Date
May 11 2020
End Date
September 30 2020
Last Update
May 9 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pusan national university hospital
Busan, South Korea, 49241